PUBLIC TRUST IN BIOTECHNOLOGY GOVERNANCE: LEGAL PRINCIPLES AND JUDICIAL APPROACH

1. INTRODUCTION

Public trust in biotechnology governance refers to the confidence citizens place in government institutions, scientific regulators, research organisations, and biotechnology companies to ensure that biotechnology is developed and used safely, ethically, transparently, and in the public interest. It is particularly important in areas such as genetically modified organisms (GMOs), gene editing, gene therapy, genetic databases, synthetic biology, and agricultural biotechnology.

Public trust is not established merely by obtaining regulatory approval. It depends on whether authorities conduct reliable scientific assessments, disclose relevant information, protect human health and the environment, prevent conflicts of interest, and provide meaningful opportunities for public participation. Trustworthy governance must balance scientific innovation with precaution, accountability, and social responsibility.

2. LEGAL FRAMEWORK GOVERNING PUBLIC TRUST

Public trust in biotechnology governance is supported by several legal principles.

A. TRANSPARENCY AND THE RIGHT TO INFORMATION

Regulatory authorities should disclose relevant safety assessments, approval conditions, environmental findings, and reasons for their decisions, subject to legitimate confidentiality and privacy restrictions. In India, the Right to Information Act, 2005, provides a framework for access to public-authority records, subject to statutory exemptions.

B. PRECAUTIONARY PRINCIPLE

Where scientific uncertainty creates a credible risk of serious environmental or public-health harm, regulators should adopt proportionate protective measures. The precautionary principle does not require rejecting every new technology; it requires reasoned risk assessment, appropriate safeguards, and continuing monitoring.

C. PUBLIC PARTICIPATION

Citizens, farmers, consumers, researchers, and affected communities should have appropriate opportunities to express concerns about biotechnology approvals and environmental releases. Authorities should consider relevant submissions rather than treating consultation as a procedural formality.

D. ACCOUNTABILITY AND INDEPENDENT SCIENTIFIC REVIEW

Regulatory decisions should be supported by competent scientific evaluation, documented reasoning, enforceable safety conditions, and effective mechanisms for investigation and remedy. Independent review helps reduce the risk that commercial interests will dominate public-health considerations.

In India, these principles operate alongside Articles 14 and 21 of the Constitution, the Environment (Protection) Act, 1986, the applicable environmental and biosafety rules, and the relevant food-safety and drug-regulatory legislation.

3. IMPORTANT CASE LAWS

1. Gene Campaign v. Union of India (2024 INSC 545) — DIRECT AUTHORITY

The Supreme Court of India considered challenges concerning the regulatory framework for genetically modified crops, particularly the environmental release of genetically modified mustard. The judgment addressed scientific assessment, biosafety regulation, transparency, and public participation. The judges expressed differing conclusions on aspects of the dispute, and the judgment did not produce a single unanimous resolution of every issue.

Legal significance: The case demonstrates that biotechnology governance requires legally defensible scientific evaluation, compliance with applicable biosafety requirements, and appropriate consideration of environmental risks. It also illustrates that public confidence is strengthened when regulatory decisions can withstand independent judicial scrutiny.

2. Gene Campaign v. Union of India, (2012) — DIRECT AUTHORITY

In this earlier biotechnology-related litigation, the Supreme Court examined issues surrounding genetically modified crops and the regulatory arrangements governing their testing and release.

Legal significance: The proceedings highlighted the importance of scientific expertise, biosafety safeguards, regulatory competence, and effective oversight. They illustrate the relationship between environmental protection and public confidence in biotechnology decision-making.

3. Vellore Citizens’ Welfare Forum v. Union of India, (1996) 5 SCC 647 — ANALOGOUS AUTHORITY

The Supreme Court recognised the precautionary principle and the polluter-pays principle as essential features of Indian environmental law.

Legal significance: Although the case did not concern biotechnology specifically, its principles are relevant where GM crops, engineered organisms, or biotechnology facilities may create uncertain environmental risks. A regulator's credibility depends on taking foreseeable harm seriously and ensuring appropriate preventive measures.

4. Indian Council for Enviro-Legal Action v. Union of India, (1996) 3 SCC 212 — ANALOGOUS AUTHORITY

The Supreme Court addressed environmental damage caused by hazardous industrial activities and emphasised the responsibility of polluting enterprises to bear the costs of remediation.

Legal significance: Biotechnology operators should not be insulated from accountability when their activities cause legally established environmental damage. Effective liability and remediation arrangements help demonstrate that public protection takes priority over private commercial advantage.

5. Research Foundation for Science, Technology and Natural Resource Policy v. Union of India, (2005) 10 SCC 510 — ANALOGOUS AUTHORITY

The Supreme Court considered environmental and public-health concerns relating to hazardous waste and the management of associated risks.

Legal significance: The decision supports the broader proposition that technical and scientific questions must be addressed through informed assessment, effective institutional oversight, and safeguards against serious harm. These considerations are relevant to biotechnology waste, laboratory containment, and environmental releases.

6. S.P. Gupta v. Union of India, 1981 Supp SCC 87 — ANALOGOUS AUTHORITY

The Supreme Court discussed open government and the public interest in disclosure of information held by public authorities, while recognising that confidentiality may be justified in appropriate circumstances.

Legal significance: Its transparency principles are relevant to public access to biosafety assessments, regulatory reasoning, and institutional decision-making. Legitimate trade secrets may require protection, but confidentiality should not become a blanket justification for withholding information necessary for meaningful public scrutiny.4. ADDITIONAL RELEVANT CASE LAWS

7. A.P. Pollution Control Board v. Prof. M.V. Nayudu, (1999) 2 SCC 718 — ANALOGOUS AUTHORITY

The Supreme Court highlighted the difficulties courts face when deciding technically complex environmental disputes and emphasised the importance of scientific expertise in environmental decision-making.

Legal significance: Biotechnology regulators should rely on qualified specialists, credible evidence, and transparent scientific reasoning. Technical complexity must not become an excuse for decisions that cannot be adequately scrutinised.

8. M.C. Mehta v. Union of India, (1987) 1 SCC 395 — ANALOGOUS AUTHORITY

In the Oleum Gas Leak case, the Supreme Court developed the principle of absolute liability for enterprises engaged in hazardous or inherently dangerous activities.

Legal significance: The case reinforces the importance of effective accountability where hazardous biotechnology operations cause harm. Although its application depends on the nature of the activity and applicable law, the principle supports public confidence in meaningful remedies for injuries caused by dangerous enterprises.

5. PRACTICAL MEASURES TO STRENGTHEN PUBLIC TRUST

Biotechnology governance should incorporate the following measures:

Publish regulatory reasons: Authorities should explain the scientific evidence, uncertainties, safety conditions, and reasons supporting approvals or refusals.

Ensure meaningful consultation: Farmers, patients, consumers, local communities, independent scientists, and civil-society organisations should have appropriate opportunities to participate.

Manage conflicts of interest: Regulators should disclose relevant financial and professional interests and establish procedures for independent review.

Maintain post-approval monitoring: Approved products should be monitored according to their risks, with reporting mechanisms for adverse events and environmental effects.

Provide accessible information: Safety findings should be communicated in understandable language and relevant regional languages wherever practicable.

Protect legitimate confidentiality: Commercial secrets and personal information should receive appropriate protection without unnecessarily concealing information essential to public safety.

Establish remedies and enforcement: Authorities should investigate violations, enforce approval conditions, and provide legally available remedies for proven harm.

The Supreme Court's 2024 decision in Gene Campaign v. Union of India is especially relevant. The two judges expressed differing views on the approval of genetically modified mustard, and the matter required further judicial consideration. The judgment also addressed the formulation of a national policy on GM crops, stakeholder consultation, and disclosure and management of experts' conflicts of interest. It therefore illustrates why scientific competence, procedural integrity, and public participation matter in biotechnology governance.

6. CONCLUSION

Public trust in biotechnology governance is a legal and institutional responsibility, not merely a communications objective. It requires regulators to combine scientific reliability with transparency, public participation, precaution, accountability, and enforceable safeguards. Indian environmental jurisprudence provides important principles for these purposes, although several cited decisions are analogous rather than biotechnology-specific precedents.

Ultimately, legitimate biotechnology governance must demonstrate that innovation serves public interests while protecting human health, environmental integrity, and constitutional values. Trust is most sustainable when citizens can understand regulatory decisions, question them through lawful procedures, and expect authorities to respond with evidence, fairness, and accountability.